NCT00838279View on ClinicalTrials.gov

Lamotrigine 25 mg Chewable Tablets, Fasting

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

February 28, 2002

Primary Completion Date

March 31, 2002

Study Completion Date

March 31, 2002

Conditions
Healthy
Interventions
DRUG

Lamotrigine 25 mg Chewable Tablets

2 x 25 mg, single-dose fasting

DRUG

Lamictal® 25 mg Chewable Tablets

2 x 25 mg, single-dose fasting

Trial Locations (1)

GIV2K8

Anapharm Inc., Sainte-Foy

All Listed Sponsors
lead

Teva Pharmaceuticals USA

INDUSTRY

NCT00838279 - Lamotrigine 25 mg Chewable Tablets, Fasting | Biotech Hunter | Biotech Hunter